Product Information
LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB is a generic product labeled by Solco Healthcare US LLC, priced at $0.0762 per EA under NDC 43547042511. Its NADAC has been published 429 times since Jul 18, 2018.
FDA first approved this application on Nov 6, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
12.5; 100 mg/1; mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547042511
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA204901FDA Approved
11/6/2017
TE Code
AB
On Market Since
2/15/2018
Pharmacological Classes
Price Statistics
The NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB has been published 429 times since Jul 18, 2018, and over the history we have for it it has declined 8.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0762 per EA |
|---|---|
| All-time high | $0.2088 (Apr 13, 2022) |
| All-time low | $0.0742 (Jul 22, 2026) |
| 52-week high | $0.0951 |
| 52-week low | $0.0742 |
| Median price | $0.1209 |
| Average price | $0.1246 |
| Largest weekly change | +42.6% (Dec 18, 2019) |
| Weeks tracked | 429 |
| Tracking since | Jul 18, 2018 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Solco Healthcare US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
losartan potassium and hydrochlorothiazide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB, manufactured by Solco Healthcare US LLC, is $0.0762 per EA (NDC 43547042511), effective Sep 30, 2026.
How has the price of LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB has declined 8.5%. It has been tracked across 429 weekly CMS publications since Jul 18, 2018.
What are the highest and lowest recorded NADAC prices for LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB?
Since Jul 18, 2018, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB has ranged from a low of $0.0742 (Jul 22, 2026) to a high of $0.2088 (Apr 13, 2022), with a median of $0.1209 per EA.
Are there cheaper alternatives to LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB, is $0.0754 per EA — about 1% below LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB.
Who manufactures LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB?
LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB (NDC 43547042511) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.